1. Expanding Capacity to Treat Hepatitis C: Overcoming Barriers and New Innovations

   • Joseph K. Lim

   Invited Commentary 17 April 2018 Pages: 83 - 87

2. Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis

   • Barbara Lattanzi
   • Daria D’Ambrosio
   • Manuela Merli

   Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors) 27 March 2018 Pages: 88 - 96

   

3. The Newest Direct-Acting Antiviral Agents: the Final Chapter in DAA Development

   • Marwa Ismail
   • Jordan J. Feld

   Hepatitis C (A Aronsohn and H Vargas, Section Editors) 07 April 2018 Pages: 97 - 104

4. Hepatitis C Virus Treatment in Non-Liver Organ Transplantation Programs

   • Eduardo A. Rodriguez
   • Bashar A. Aqel

   Hepatitis C (A Aronsohn and H Vargas, Section Editors) 05 April 2018 Pages: 105 - 110

5. Strategies for the Elimination of Hepatitis C Virus Infection as a Public Health Threat in the United States

   • Charitha Gowda
   • Vincent Lo Re III

   Hepatitis C (A Aronsohn and H Vargas, Section Editors) 24 March 2018 Pages: 111 - 120

   

6. Treatment of DAA-Experienced Patients with Chronic Hepatitis C

   • Maria A. Corcorran
   • John D. Scott

   Hepatitis C (A Aronsohn and H Vargas, Section Editors) 24 March 2018 Pages: 121 - 129

   

7. Extrahepatic Malignancies in Primary Biliary Cholangitis

   • Annarosa Floreani
   • Maria Francesca Secchi

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 20 March 2018 Pages: 130 - 134

8. Ethnic and Racial Differences in Autoimmune Liver Diseases

   • Arnaldo Freire
   • Cynthia Levy

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 26 April 2018 Pages: 135 - 142

9. Therapeutics for Pruritus in Cholestatic Liver Disease: Many Treatments but Few Cures

   • Mark Pederson
   • Marlyn J. Mayo

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 06 April 2018 Pages: 143 - 151